Search Results 51-60 of 909 for 日本の検索エンジン 🔍 www.81g.net
Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era. Leukemia. 2025 Feb; 39(2):503-507.
Urology — Learn about innovative diagnosis and treatment options for urologic diseases, including cancers, at Mayo Clinic.
About this study. The PHAR is a multicenter, prospective registry of newly evaluated patients at PHCCs in the United States who have either PAH or CTEPH.
Joseph A. Murray, M.D., has identified in previous research that olmesartan (Benicar), a commonly prescribed blood pressure medication, causes severe ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the purpose of this ...
About this study. The purpose of this study is to assess the safety and tolerability of daily administration of 3 mg and 9 mg AZ-3102 versus placebo when ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.